Stockholm3
Blood-based prostate cancer risk test integrating PSA, additional proteins, a polygenic risk score and clinical variables.
- Developer
- A3P Biomedical
- Intended use
- Risk Stratification
- Cancer scope
- Prostate cancer
- Specimen
- Whole blood
- Molecular modality
- DNA, Multi-omics, Protein
- Current version
- Current Stockholm3 configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.